{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:09:27Z","timestamp":1790680167620,"version":"4.1.0"},"reference-count":78,"publisher":"MDPI AG","issue":"20","license":[{"start":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T00:00:00Z","timestamp":1634601600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJERPH"],"abstract":"<jats:p>The role of opioids and opioid medications in ADHD symptoms is still largely understudied. We tested the hypothesis that, in Heroin Use Disorder (HUD), when patients are treated with Agonist Opioid medications (AOT), treatment outcome is associated with the presence of Adult Attention-Deficit\/Hyperactive Disorder (A-ADHD) symptomatology. A retrospective cohort study of 130 HUD patients in Castelfranco Veneto, Italy, covering 30 years, was divided into two groups according to the Adult ADHD Self-Report Scale (ASRS) score and compared them using demographic, clinical and pharmacological factors. Survival in treatment was studied by utilizing the available data for leaving treatment and relapsing into addictive behavior and for mortality during treatment as poor primary outcomes. Thirty-five HUD subjects (26.9%) were unlikely to have A-ADHD symptomatology, and 95 (73.1%) were likely to have it. Only current age and co-substance use at treatment entry differed significantly between groups. Censored patients were 29 (82.9%) for HUD patients and 70 (73.9%) for A-ADHD\/HUD patients (Mantel-Cox test = 0.66 p = 0.415). There were no significant linear trends indicative of a poorer outcome with the presence of A-ADHD after adjustment for demographic, clinical and pharmacological factors. Conclusions: ADHD symptomatology does not seem to exert any influence on the retention in AOT of HUD patients.<\/jats:p>","DOI":"10.3390\/ijerph182010997","type":"journal-article","created":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T03:01:13Z","timestamp":1634698873000},"page":"10997","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Adult-Attention Deficit Hyperactive Disorder Symptoms Seem Not to Influence the Outcome of an Enhanced Agonist Opioid Treatment: A 30-Year Follow-Up"],"prefix":"10.3390","volume":"18","author":[{"given":"Angelo G. I.","family":"Maremmani","sequence":"first","affiliation":[{"name":"North-Western Tuscany Local Health Unit, Department of Psychiatry, Tuscany NHS, Versilia Zone, 55049 Viareggio, Italy"},{"name":"Association for the Application of Neuroscientific Knowledge to Social Aims (AU-CNS), 55045 Pietrasanta, Italy"},{"name":"PISA-School of Experimental and Clinical Psychiatry, 56100 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasqualina","family":"Rocco","sequence":"additional","affiliation":[{"name":"Drug Addiction Unit, 31033 Castelfranco Veneto, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7935-3524","authenticated-orcid":false,"given":"Filippo Della","family":"Rocca","sequence":"additional","affiliation":[{"name":"School of Psychiatry, Department of Clinical and Experimental Psychiatry, University of Pisa, 56100 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5556-1858","authenticated-orcid":false,"given":"Giulio","family":"Perugi","sequence":"additional","affiliation":[{"name":"VP Dole Dual Disorder Research Group, 2nd Psychiatric Unit, Department of Clinical and Experimental Psychiatry, University of Pisa, 56100 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Miccoli","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Pisa, 56100 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6324-0576","authenticated-orcid":false,"given":"Icro","family":"Maremmani","sequence":"additional","affiliation":[{"name":"Association for the Application of Neuroscientific Knowledge to Social Aims (AU-CNS), 55045 Pietrasanta, Italy"},{"name":"Saint Camillus International University of Health and Medical Sciences\u2014UniCamillus, 00131 Rome, Italy"},{"name":"G. De Lisio Institute of Behavioural Sciences, 56100 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,10,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1177\/1087054715573992","article-title":"Prevalence and Correlates of Self-Reported ADD\/ADHD in a Large National Sample of Canadian Adults","volume":"22","author":"Hesson","year":"2018","journal-title":"J. Atten. Disord."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1176\/ajp.2006.163.4.716","article-title":"The Prevalence and Correlates of Adult ADHD in the United States: Results from the National Comorbidity Survey Replication","volume":"163","author":"Kessler","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"3S","DOI":"10.1177\/1087054711435361","article-title":"Distinguishing Comorbidity and Successful Management of Adult ADHD","volume":"16","author":"Kooij","year":"2012","journal-title":"J. Atten. Disord."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1037\/a0023961","article-title":"Distinguishing sluggish cognitive tempo from attention-deficit\/hyperactivity disorder in adults","volume":"121","author":"Barkley","year":"2012","journal-title":"J. Abnorm. Psychol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3810\/pgm.2014.09.2799","article-title":"Comorbidities in Adult Attention-Deficit\/Hyperactivity Disorder: A Practical Guide to Diagnosis in Primary Care","volume":"126","author":"Mao","year":"2014","journal-title":"Postgrad. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1017\/S003329170500471X","article-title":"The age-dependent decline of attention deficit hyperactivity disorder: A meta-analysis of follow-up studies","volume":"36","author":"Faraone","year":"2005","journal-title":"Psychol. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1001\/archgenpsychiatry.2012.271","article-title":"Clinical and Functional Outcome of Childhood Attention-Deficit\/Hyperactivity Disorder 33 Years Later","volume":"69","author":"Klein","year":"2012","journal-title":"Arch. Gen. Psychiatry"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/sj.mp.4001869","article-title":"The analysis of 51 genes in DSM-IV combined type attention deficit hyperactivity disorder: Association signals in DRD4, DAT1 and 16 other genes","volume":"11","author":"Brookes","year":"2006","journal-title":"Mol. Psychiatry"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/acps.12845","article-title":"Gender differences in psychiatric comorbidity: A population-based study of 40 000 adults with attention deficit hyperactivity disorder","volume":"137","author":"Solberg","year":"2018","journal-title":"Acta Psychiatr. Scand."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1176\/ajp.2006.163.9.1561","article-title":"Prevalence and effects of mood disorders on work performance in a nationally representative sample of U.S. workers","volume":"163","author":"Kessler","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.jaac.2011.01.021","article-title":"Does ADHD Predict Substance-Use Disorders? A 10-Year Follow-up Study of Young Adults With ADHD","volume":"50","author":"Wilens","year":"2011","journal-title":"J. Am. Acad. Child. Adolesc. Psychiatry"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/dar.12249","article-title":"Comorbid attention deficit hyperactivity disorder and substance use disorder complexity and chronicity in treatment-seeking adults","volume":"34","author":"Young","year":"2015","journal-title":"Drug Alcohol Rev."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12888-017-1463-3","article-title":"Adult ADHD and comorbid disorders: Clinical implications of a dimensional approach","volume":"17","author":"Katzman","year":"2017","journal-title":"BMC Psychiatry"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.addbeh.2008.05.003","article-title":"Correlates of co-occurring ADHD in drug-dependent subjects: Prevalence and features of substance dependence and psychiatric disorders","volume":"33","author":"Arias","year":"2008","journal-title":"Addict. Behav."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Kooij, J.J.S., R\u00f6sler, M., Philipsen, A., W\u00e4chter, S., Dejonckheere, J., Van Der Kolk, A., Van Agthoven, M., and Sch\u00e4uble, B. (2013). Predictors and impact of non-adherence in adults with attention-deficit\/hyperactivity disorder receiving OROS methylphenidate: Results from a randomized, placebo-controlled trial. BMC Psychiatry, 13.","DOI":"10.1186\/1471-244X-13-36"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1515\/ijamh-2013-0057","article-title":"Attention deficit hyperactivity disorder and dual disorders. Educational needs for an underdiagnosed condition","volume":"25","author":"Szerman","year":"2013","journal-title":"Int. J. Adolesc. Med. Health"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1080\/14656566.2019.1618270","article-title":"Current and emerging pharmacotherapy for the treatment of adult attention deficit hyperactivity disorder (ADHD)","volume":"20","author":"Perugi","year":"2019","journal-title":"Expert Opin. Pharmacother."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"935","DOI":"10.4088\/JCP.08lr04878","article-title":"Self-medication, bipolar disorders, and stimulant dependence","volume":"70","author":"Khantzian","year":"2009","journal-title":"J. Clin. Psychiatry"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1469-7610.2010.02309.x","article-title":"The Child Behavior Checklist-Dysregulation Profile predicts substance use, suicidality, and functional impairment: A longitudinal analysis","volume":"52","author":"Holtmann","year":"2011","journal-title":"J. Child. Psychol. Psychiatry"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/00005053-197802000-00001","article-title":"Hyperactivity: Diagnostic confusion","volume":"166","author":"Schuckit","year":"1978","journal-title":"J. Nerv. Ment. Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/00005053-198209000-00002","article-title":"History of Childhood Hyperactivity in a Clinic Population of Opiate Addicts","volume":"170","author":"Eyre","year":"1982","journal-title":"J. Nerv. Ment. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/00005053-199908000-00005","article-title":"Attention Deficit Hyperactivity Disorder and Treatment Outcome in Opioid Abusers Entering Treatment","volume":"187","author":"King","year":"1999","journal-title":"J. Nerv. Ment. Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1080\/10601330601080073","article-title":"Influence of Attention-Deficit\/Hyperactivity Disorder Symptoms on Methadone Treatment Outcome","volume":"16","author":"Kolpe","year":"2007","journal-title":"Am. J. Addict."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Manni, C., Cipollone, G., Pallucchini, A., Maremmani, A.G.I., Perugi, G., and Maremmani, I. (2019). Remarkable Reduction of Cocaine Use in Dual Disorder (Adult Attention Deficit Hyperactive Disorder\/Cocaine Use Disorder) Patients Treated with Medications for ADHD. Int. J. Environ. Res. Public Health, 16.","DOI":"10.3390\/ijerph16203911"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1001\/jama.1965.03090080008002","article-title":"A medical treatment for diacetylmorphine (heroin) addiction: A clinical trial with methadone hydrocloride","volume":"193","author":"Dole","year":"1965","journal-title":"JAMA"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1001\/jama.1968.03150120042009","article-title":"Successful treatment of 750 criminal addicts","volume":"206","author":"Dole","year":"1968","journal-title":"JAMA"},{"key":"ref_27","first-page":"41","article-title":"Nearly thirty years of experience of real-world long-term treatment with Agonist Opioids","volume":"22","author":"Lamanna","year":"2020","journal-title":"Heroin Addict. Relat. Clin. Probl."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1176\/ajp.142.11.1259","article-title":"The self-medication hypothesis of addictive disorders: Focus on heroin and cocaine dependence","volume":"142","author":"Khantzian","year":"1985","journal-title":"Am. J. Psychiatry"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3109\/10673229709030550","article-title":"The Self-Medication Hypothesis of Substance Use Disorders: A Reconsideration and Recent Applications","volume":"4","author":"Khantzian","year":"1997","journal-title":"Harv. Rev. Psychiatry"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1521-0391.2013.12086.x","article-title":"The self-medication hypothesis and psychostimulant treatment of cocaine dependence: An update","volume":"23","author":"Mariani","year":"2013","journal-title":"Am. J. Addict."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Spera, V., Pallucchini, A., Carli, M., Maiello, M., Maremmani, A., Perugi, G., and Maremmani, I. (2021). Does Cannabis, Cocaine and Alcohol Use Impact Differently on Adult Attention Deficit\/Hyperactivity Disorder Clinical Picture?. J. Clin. Med., 10.","DOI":"10.3390\/jcm10071481"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Spera, V., Pallucchini, A., Maiello, M., Carli, M., Maremmani, A.G.I., Perugi, G., and Maremmani, I. (2020). Substance Use Disorder in Adult-Attention Deficit Hyperactive Disorder Patients: Patterns of Use and Related Clinical Features. Int. J. Environ. Res. Public Health, 17.","DOI":"10.3390\/ijerph17103509"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.tins.2015.04.002","article-title":"NOW vs LATER brain circuits: Implications for obesity and addiction","volume":"38","author":"Volkow","year":"2015","journal-title":"Trends Neurosci."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2165\/00023210-200418010-00004","article-title":"Cognitive Effects of Long-Term Benzodiazepine Use: A meta-analysis","volume":"18","author":"Barker","year":"2004","journal-title":"CNS Drugs"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/da.20891","article-title":"Memory dysfunction in panic disorder: An investigation of the role of chronic benzodiazepine use","volume":"28","author":"Deckersbach","year":"2011","journal-title":"Depress. Anxiety"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1093\/arclin\/acx120","article-title":"The Residual Medium and Long-term Cognitive Effects of Benzodiazepine Use: An Updated Meta-analysis","volume":"33","author":"Crowe","year":"2018","journal-title":"Arch. Clin. Neuropsychol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0887-6177(03)00096-9","article-title":"Persistence of cognitive effects after withdrawal from long-term benzodiazepine use: A meta-analysis","volume":"19","author":"Barker","year":"2004","journal-title":"Arch. Clin. Neuropsychol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s00702-020-02285-w","article-title":"Adult attention-deficit\/hyperactivity disorder symptoms, cognitive dysfunction and quality of life in high-dose use of benzodiazepine and Z-drug","volume":"128","author":"Federico","year":"2020","journal-title":"J. Neural Transm."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1159\/000505207","article-title":"Association between Adult Attention Deficit\/Hyperactivity Disorder and Intravenous Misuse of Opioid and Benzodiazepine in Patients under Opioid Maintenance Treatment: A Cross-Sectional Multicentre Study","volume":"26","author":"Lugoboni","year":"2020","journal-title":"Eur. Addict. Res."},{"key":"ref_40","first-page":"69","article-title":"Early-readmission after Agonist Opioid Treatment in five European countries. A drug addiction health policy challenge?","volume":"23","author":"Maremmani","year":"2021","journal-title":"Heroin Addict. Relat. Clin. Probl."},{"key":"ref_41","first-page":"10","article-title":"The quality of life of adults with attention deficit hyperactivity disorder: A systematic review","volume":"9","author":"Agarwal","year":"2012","journal-title":"Innov. Clin. Neurosci."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1001\/archpsyc.1993.01820190067007","article-title":"Adult Outcome of Hyperactive Boys. Educational achievement, occupational rank, and psychiatric status","volume":"50","author":"Mannuzza","year":"1993","journal-title":"Arch. Gen. Psychiatry"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jsat.2012.07.001","article-title":"Predictors of treatment response in adolescents with comorbid substance use disorder and attention-deficit\/hyperactivity disorder","volume":"44","author":"Tamm","year":"2013","journal-title":"J. Subst. Abus. Treat."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0010-440X(93)90050-E","article-title":"History and significance of childhood attention deficit disorder in treatment-seeking cocaine abusers","volume":"34","author":"Carroll","year":"1993","journal-title":"Compr. Psychiatry"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1016\/j.addbeh.2004.03.041","article-title":"Impact of attention-deficit hyperactivity disorder and other psychopathology on treatment retention among cocaine abusers in a therapeutic community","volume":"29","author":"Levin","year":"2004","journal-title":"Addict. Behav."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/j.1360-0443.2007.01849.x","article-title":"Improving drug addiction treatment in China","volume":"102","author":"Tang","year":"2007","journal-title":"Addiction"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1744-859X-11-23","article-title":"Clinical presentations of substance abuse in bipolar heroin addicts at time of treatment entry","volume":"11","author":"Maremmani","year":"2012","journal-title":"Ann. Gen. Psychiatry"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.pbb.2011.04.014","article-title":"Powerful behavioral interactions between methamphetamine and morphine","volume":"99","author":"Trujillo","year":"2011","journal-title":"Pharmacol. Biochem. Behav."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1006\/mcne.1994.1039","article-title":"Distribution of \u03ba Opioid Receptor mRNA in Adult Mouse Brain: An in Situ Hybridization Histochemistry Study","volume":"5","author":"DePaoli","year":"1994","journal-title":"Mol. Cell. Neurosci."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0165-3806(98)00082-0","article-title":"Opioid receptor gene expression in the rat brain during ontogeny, with special reference to the mesostriatal system: An in situ hybridization study","volume":"109","author":"Georges","year":"1998","journal-title":"Dev. Brain Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.lfs.2003.10.041","article-title":"Agonist-induced regulation and trafficking of $kappa; opioid receptors","volume":"75","year":"2004","journal-title":"Life Sci."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"7006","DOI":"10.1073\/pnas.92.15.7006","article-title":"kappa-Opioid receptor in humans: cDNA and genomic cloning, chromosomal assignment, functional expression, pharmacology, and expression pattern in the central nervous system","volume":"92","author":"Simonin","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"6736","DOI":"10.1073\/pnas.90.14.6736","article-title":"Cloning and functional comparison of kappa and delta opioid receptors from mouse brain","volume":"90","author":"Yasuda","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00213-010-1806-y","article-title":"Kinase cascades and ligand-directed signaling at the kappa opioid receptor","volume":"210","author":"Bruchas","year":"2010","journal-title":"Psychopharmacology"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/da.22500","article-title":"Kappa-Opioid Antagonists for Psychiatric Disorders: From Bench to Clinical Trials","volume":"33","author":"Carlezon","year":"2016","journal-title":"Depress. Anxiety"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1126\/science.282.5397.2272","article-title":"Regulation of Cocaine Reward by CREB","volume":"282","author":"Carlezon","year":"1998","journal-title":"Science"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1124\/jpet.107.127415","article-title":"Anxiolytic-Like Effects of \u03ba-Opioid Receptor Antagonists in Models of Unlearned and Learned Fear in Rats","volume":"323","author":"Knoll","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1523\/JNEUROSCI.4458-07.2008","article-title":"The Dysphoric Component of Stress Is Encoded by Activation of the Dynorphin -Opioid System","volume":"28","author":"Land","year":"2008","journal-title":"J. Neurosci."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1038\/sj.npp.1300872","article-title":"Social Defeat Stress-Induced Behavioral Responses are Mediated by the Endogenous Kappa Opioid System","volume":"31","author":"McLaughlin","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/sj.npp.1301438","article-title":"Pharmacological Evidence for a Motivational Role of \u03ba-Opioid Systems in Ethanol Dependence","volume":"33","author":"Walker","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/jnr.20890","article-title":"Repeated administration of the selective kappa-opioid receptor agonist U-69593 increases stimulated dopamine extracellular levels in the rat nucleus accumbens","volume":"84","author":"Fuentealba","year":"2006","journal-title":"J. Neurosci. Res."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1073\/pnas.0511159103","article-title":"opioids selectively control dopaminergic neurons projecting to the prefrontal cortex","volume":"103","author":"Margolis","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/0028-3908(87)90077-3","article-title":"Opioid receptor regulation of the release of norepinephrine in brain","volume":"26","author":"Werling","year":"1987","journal-title":"Neuropharmacology"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"5674","DOI":"10.1523\/JNEUROSCI.23-13-05674.2003","article-title":"Kappa opioid receptor antagonism and prodynorphin gene disruption block stress-induced behavioral responses","volume":"23","author":"Mclaughlin","year":"2003","journal-title":"J. Neurosci."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"4083","DOI":"10.1016\/j.bmcl.2004.05.018","article-title":"Synthesis and biological evaluation of the major metabolite of atomoxetine: Elucidation of a partial \u03ba-opioid agonist effect","volume":"14","author":"Creighton","year":"2004","journal-title":"Bioorganic Med. Chem. Lett."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1080\/14740338.2016.1200209","article-title":"Atomoxetine, ADHD, and the ongoing debate about increased risk of suicidal behaviors: The understudied role of kappa opioid receptor agonism","volume":"15","author":"Fluegge","year":"2016","journal-title":"Expert Opin. Drug Saf."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.brainres.2006.12.079","article-title":"Effects of early methylphenidate exposure on morphine- and sucrose-reinforced behaviors in adult rats: Relationship to dopamine D2 receptors","volume":"1139","author":"Crawford","year":"2007","journal-title":"Brain Res."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.pbb.2008.11.011","article-title":"Methylphenidate potentiates morphine-induced antinociception, hyperthermia, and locomotor activity in young adult rats","volume":"92","author":"Halladay","year":"2009","journal-title":"Pharmacol. Biochem. Behav."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1038\/npp.2008.188","article-title":"\u03ba-Opioid System Regulates the Long-Lasting Behavioral Adaptations Induced by Early-Life Exposure to Methylphenidate","volume":"34","author":"Wiley","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF02244763","article-title":"\u03bc-Opioid receptor and \u03b12-adrenoceptor agonist binding sites in the postmortem brain of heroin addicts","volume":"115","author":"Gabilondo","year":"1994","journal-title":"Psychopharmacology"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"R1475","DOI":"10.1152\/ajpregu.1995.269.6.R1475","article-title":"Alterations of energy and substrate metabolism in rats with large and sustained changes in daily food intake","volume":"269 Pt. 2","author":"Wang","year":"1995","journal-title":"Am. J. Physiol. Integr. Comp. Physiol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0893-133X(00)00209-8","article-title":"Striatal Dopaminergic and Serotonergic Markers in Human Heroin Users","volume":"24","author":"Kish","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1159\/000026521","article-title":"Enlarged cerebrospinal fluid spaces in opiate-dependent male patients: A stereological CT study","volume":"38","author":"Danos","year":"1998","journal-title":"Neuropsychobiology"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1159\/000026502","article-title":"Pathological Regional Cerebral Blood Flow in Opiate-Dependent Patients during Withdrawal: A HMPAO-SPECT Study","volume":"37","author":"Danos","year":"1998","journal-title":"Neuropsychobiology"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0925-4927(98)00030-4","article-title":"Regional cerebral blood flow and comorbid diagnosis in abstinent opioid addicts","volume":"83","author":"Gerra","year":"1998","journal-title":"Psychiatry Res. Neuroimaging"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00213-005-0198-x","article-title":"Prefrontal and temporal gray matter density decreases in opiate dependence","volume":"184","author":"Lyoo","year":"2005","journal-title":"Psychopharmacology"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0925-4927(96)02663-7","article-title":"Cerebral perfusion in early and late opiate withdrawal: A technetium-99m-HMPAO SPECT study","volume":"67","author":"Rose","year":"1996","journal-title":"Psychiatry Res. Neuroimaging"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0925-4927(98)00028-6","article-title":"Cerebral CT findings in male opioid-dependent patients: Stereological, planimetric and linear measurements","volume":"83","author":"Pezawas","year":"1998","journal-title":"Psychiatry Res. Neuroimaging"}],"container-title":["International Journal of Environmental Research and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1660-4601\/18\/20\/10997\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:18:21Z","timestamp":1760167101000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1660-4601\/18\/20\/10997"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,19]]},"references-count":78,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2021,10]]}},"alternative-id":["ijerph182010997"],"URL":"https:\/\/doi.org\/10.3390\/ijerph182010997","relation":{},"ISSN":["1660-4601"],"issn-type":[{"value":"1660-4601","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,19]]}}}